Wired·4 min read·medium
An FDA Panel Just Endorsed These Unproven Peptides
E
Emily Mullin
✦AI Summary
An FDA advisory panel has narrowly recommended reclassifying four peptides to allow compounding pharmacies to produce them, despite concerns from FDA scientists. These substances, often promoted by influencers, currently exist in a largely unregulated market.
A panel of experts on Thursday narrowly recommended that the Food and Drug Administration reclassify four popular peptides—including one endorsed by podcaster Joe Rogan—to allow certain pharmacies to legally dispense them.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in